A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Public ClinicalTrials.gov record NCT05649137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect and Safety of Semaglutide 7.2 mg Once-weekly in Participants With Obesity and Type 2 Diabetes
Study identification
- NCT ID
- NCT05649137
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 512 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Semaglutide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2023
- Primary completion
- Oct 27, 2024
- Completion
- Dec 12, 2024
- Last update posted
- Apr 26, 2026
2023 – 2024
United States locations
- U.S. sites
- 23
- U.S. states
- 9
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama Birmingham | Birmingham | Alabama | 35222 | — |
| Chambliss Clinical Trials, LLC | Montgomery | Alabama | 36106 | — |
| John Muir Physicians Network | Concord | California | 94520 | — |
| Velocity Clinical Research Westlake | Los Angeles | California | 90057 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| New West Physicians PC | Golden | Colorado | 80401 | — |
| ARS- Deland CRU | DeLand | Florida | 32720 | — |
| Jacksonville Ctr for Clin Res | Jacksonville | Florida | 32216 | — |
| Florida Inst For Clin Res LLC | Orlando | Florida | 32825 | — |
| Oviedo Medical Research, LLC | Oviedo | Florida | 32765 | — |
| Hope Clin Res & Wellness | Conyers | Georgia | 30094 | — |
| AMC Community Endocrinology | Albany | New York | 12203 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| PharmQuest Life Sciences LLC | Greensboro | North Carolina | 27408 | — |
| Amarillo Med Spec LLP | Amarillo | Texas | 79106 | — |
| Elligo Clin Res Centre | Austin | Texas | 78704 | — |
| Velocity Clin Res, Dallas | Dallas | Texas | 75230 | — |
| UT Southwestern Medical Center - Lingvay | Dallas | Texas | 75390 | — |
| PlanIt Research, PLLC | Houston | Texas | 77079 | — |
| DCOL Ctr for Clin Res | Longview | Texas | 75605 | — |
| Sugar Lakes Family Practice PA | Sugar Land | Texas | 77479 | — |
| National Clin Res Inc. | Richmond | Virginia | 23294 | — |
| Selma Medical Associates | Winchester | Virginia | 22601-3834 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05649137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2026 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05649137 live on ClinicalTrials.gov.